B*2701 differs from all other HLA-B27 subtypes
of known peptide specificity in that, among its natural
peptide ligands, arginine is not the only allowed residue
at peptide position 2. Indeed, B*2701 is unique in binding
many peptides with Gln2 in vivo. However, the mutation
(Asp74Tyr) responsible for altered selectivity is far away
from the B pocket of the peptide binding site to which
Gln/Arg2 binds. Here, we present a model that explains
this effect. It is proposed that a new rotameric state
of the conserved Lys70 is responsible for the unique B*2701
binding motif. This side chain should be either kept away
from pocket B through its interaction with Asp74 in most
HLA-B27 subtypes, or switched to this pocket if residue
74 is Tyr as in B*2701. Involvement of Lys70 in pocket
B would thus allow binding of peptides with Gln2. Binding
of Arg2-containing peptides to B*2701 is also possible
because Lys70 could adopt another conformation, H-bonded
to Asn97, which preserves the same binding mode of Arg2
as in B*2705. This model was experimentally validated by
mutating Lys70 into Ala in B*2701. Edman sequencing of
the B*2701(K70A) peptide pool showed only Arg2, characteristic
of HLA-B27-bound peptides, and no evidence for Gln2. This
supports the computational model and demonstrates that
allowance of B*2701 for peptides with Gln2 is due to the
long-range effect of the polymorphic residue 74 of HLA-B27,
by inducing a conformational switch of the conserved Lys70.